Hypothalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis

Rodriguez-Valverde, 1997, Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica, Am J Med, 102, 331, 10.1016/S0002-9343(97)00117-4 Rodriguez-Valverde, 1993, Vasculitis: Concepto, etiopatogenia y clasificacion, Rev Esp Reumatol, 20, 355 Martinez-Taboada, 1994, Conceptos actuales sobre la patogenia de la arteritis de células gigantes, Rev Esp Reumatol, 21, 293 Weyand, 1995, Giant cell arteritis as an antigen driven disease, Rheum Dis Clin North Am, 21, 1027, 10.1016/S0889-857X(21)00483-X Roshan, 1999, Review: ageing and hormones, Eur J Clin Invest, 29, 210, 10.1046/j.1365-2362.1999.00436.x Ferrari, 2001, Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates, Eur J Endocrinol, 144, 319, 10.1530/eje.0.1440319 Chuang, 1982, Polymyalgia rheumatica: a 10-year epidemiologic and clinical study, Ann Intern Med, 97, 672, 10.7326/0003-4819-97-5-672 Hunder, 1990, The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis, Arthrirtis Rheum, 33, 1122, 10.1002/art.1780330810 Bridges, 1998, Cortisol, androstenedione (A4), dehydroepiandrosterone sulphate (DHEAS) and 17 hydroxyprogesterone (17OHP) responses to low doses of (1-24) ACTH, J Clin Endocrinol Metab, 83, 3750, 10.1210/jc.83.10.3750 Hurel, 1996, The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis, Clin Endocrinol, 44, 141, 10.1046/j.1365-2265.1996.555381.x Martinez-Taboada, 2002, Changes in peripheral blood lymphocyte subsets in elderly subjects are associated with an impaired function of the hypothalamic-pituitary-adrenal axis, Mech Aging Dev., 123, 1477, 10.1016/S0047-6374(02)00116-1 Castle, 2000, Clinical relevance of age-related immune dysfunction, Clin Infect Dis, 31, 578, 10.1086/313947 Straub, 2000, The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumor necrosis factor) in polymyalgia rheumatica, Rheumatology, 39, 624, 10.1093/rheumatology/39.6.624 van der Berghe, 2001, Neuroendocrine response to acute versus prolonged critical illness, 2094 Orentreich, 1984, Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood, J Clin Endocrinol Metab, 59, 551, 10.1210/jcem-59-3-551 Sternberg, 1992, The stress response and the regulation of inflammatory disease, Ann Intern Med, 117, 854, 10.7326/0003-4819-117-10-854 Roche, 1993, Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis, Arthritis Rheum, 36, 1286, 10.1002/art.1780360913 Wagner, 1994, Functional profile of tissue infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease, J Clin Invest, 94, 1134, 10.1172/JCI117428 Cutolo, 2000, Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease, Clin Exp Rheumatol, 18, 655 Foppiani, 1999, Desmopressin, ovine CRH, and low-dose ACTH tests: tools for the study of the hypothalamic-pituitary-adrenal axis in premenopausal rheumatoid arthritis patients, Ann N Y Acad Sci, 876, 83, 10.1111/j.1749-6632.1999.tb07625.x